Brewery craft beer has really taken off in the last decade and many taprooms are catching on to the public's appetite for ...

A new locally owned, downtown Phoenix cafe pairs James Beard-worthy pastries with Brazilian coffee from the owners’ family ...

Quarterly GMV, Revenue and Adjusted EBITDA results at or above top end of guidance ranges Third Quarter 2025 Free Cash Flow increases 246% year-over-year to $73.6 million PETAH-TIKVA, Israel, Nov.

The Week 11 Weekend Waiver Wire starts now. Mike Reedy scours fantasy football free-agent lists for emerging value this ...

Commercially Launched ORLYNVAH in the United States in August 2025-- --Extended Cash Runway into Q2 2026-- --Company to host conference call today at 8:30amET-- DUBLIN, Ireland and CHICAGO, Nov. 14 ...

SAN DIEGO, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the third quarter ended September 30, 2025.

Cost of sales expense for the third quarter 2025 was $0.02 million and primarily consists of royalty payments pursuant to Iterum’s license agreement with Pfizer Inc (Pfizer). Prior to approval in ...

Objective To assess the effects of behaviourally informed short message service (SMS) reminders on demand for human ...